The Center Faculty come from all four UCSF Schools and conduct research and teaching in every aspect of tobacco control, from efforts by the tobacco industry to manipulate international politics to the molecular biology of nicotine addiction.

Stuart Gansky, MS, DrPH

Preventive & Restor Dent Sci

Oral health research, health disparities research, applied statistical analyses and related methodological issues.

Peter Ganz

Chief, Cardiology/SFGH

Cardiovascular effects and potential harms of conventional, new and emerging tobacco products.

Warren Gold, MD

Professor Emeritus

Long-term effects of second hand cigarette smoke on flight attendants.

Jeffrey Gotts, MD, PhD

Assistant Professor

Effects of cigarette smoke and e-cigarette aerosols on susceptibility to acute respiratory distress syndrome (ARDS), a major cause of respiratory failure in critically ill patients.

Jennifer Grandis, MD

Professor, Otolaryngology – Head and Neck Surgery, Associate Vice Chancellor, Clinical and Translational Science Institute

Signal transduction in head and neck squamous cell carcinoma (tobacco-caused cancers) development and progression with the ultimate goal of targeting key pathways for therapeutic benefit.

Lawrence Green, DrPH, MPH

Professor Emeritus
Epidemiology & Biostatistics

Health promotion, including tobacco control, with particular emphasis on knowledge dissemination, transfer, program planning and implementation strategies in making practice more evidence-based by making evidence more practice-based.

Valerie Gribben, MD

HS Asst Clinical Professor

Valerie Gribben, MD, FAAP is an Assistant Professor of Pediatrics at UCSF.  Research interests include: reducing primary and secondhand vaping, cigarette, and marijuana exposure in children and teens; vaping patterns of teenagers during the COVID-19 pandemic; the intersection between digital usage and vaping; social media interventions to assist in vaping cessation; and health disparities in tobacco use and exposure. 

Joe Guydish, PhD

Institute for Health Policy Studies

Access, delivery, and organization of substance abuse treatment services, treatment effectiveness, and adoption of new treatments into practice settings with current focus an organizational change intervention for treatment programs in tobacco dependence.

Sharon Hall, PhD

Professor Emeritus

Clinical trials for the treatment of nicotine dependence, with emphasis on treatments that reflect a chronic disease model, and on complex populations.

Judith Hellman, MD


My research program is focused on basic and translational research on sepsis and other forms of inflammation-driven acute organ failure ("Inflammatory Critical Illness"). Sepsis and multiple organ failure are leading causes of death in the Intensive Care Unit. These processes result from a complex inflammatory response that is initiated through the innate immune system by interactions between host cells and microbes or endogenous host factors that are released during injury or cell death. The family of Toll-like receptors (TLRs) recognize different microbial components and endogenous host factors, and are critical in initiating inflammatory responses to infection. The Hellman Group studies TLR-dependent pathways expressed by macrophages as well as non-conventional inflammatory cells, including endothelial cells, in Inflammatory Critical Illness, focusing on their roles in coagulopathy, vascular permeability, neutrophil trafficking to organs, and organ injury and failure.